Association of botox with microsurgery of the nasal septum depressor muscle in the treatment of gingival smile.

The influence of microsurgery of the nasal septum depressor muscle associated with botulinum toxin in the treatment of gingival smile.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-5x9ry6s

Enrollment

Unknown

Registered

2022-01-26

Start date

2020-01-30

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Excessive gum exposure when smiling

Interventions

The randomized clinical trial consisted of 25 patients, randomly divided into two groups, with a gummy smile above 2 mm: Group I, 12 patients, mean age of 37.7 years (SD ± 9.24) and Group II, 13 patie

D08.811.277.656.300.480.153.100

Eligibility

Age

18 Years to 66 Years

Inclusion criteria

Inclusion criteria: Gummy smile above 2mm

Exclusion criteria

Exclusion criteria: Gingival exposure excess (skeletal); use of antibiotics and muscle relaxant: pregnancy and pregnancy; under 18

Design outcomes

Primary

Measure	Time frame
Group I presented a more stable result than group II (pre-application) when compared to phase T1 with T4 (180 days).	—

Secondary

Measure	Time frame
Secondary outcomes are not expected.	—

Countries

Brazil

Contacts

Public ContactHewerlen Pinheiro

hcodontologia@yahoo.com.br+551932113600

Outcome results

None listed

Source: REBEC (via WHO ICTRP)